ClinicalTrials.Veeva

Menu

Application of Direct Current Transcranial stImulation, Remotely superVised in Chronic fATiguE (ACTIVATE)

U

University of Regensburg (UR)

Status

Enrolling

Conditions

Myalgic Encephalomyelitis/Chronic Fatigue Syndrome

Treatments

Device: home-based transcranial direct current stimulation (tDCS)

Study type

Interventional

Funder types

Other

Identifiers

NCT05791812
22-3028-101

Details and patient eligibility

About

It is a one-arm open-label interventional study with transcranial direct current stimulation in an remote home-based setting with the aims to evaluate the feasibility (usability of the device, compliance of patients, usability of the teletherapy), the effectiveness (clinical ratings) and the compatability of this intervention in 20 patients with myalgic encephalomyelitis/chronic fatigue syndrome.

Enrollment

20 estimated patients

Sex

All

Ages

18 to 70 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • ME/CFS diagnosis according to the Canadian Consensus Criteria
  • residence near Regensburg and mother language German
  • written informed consent
  • stable medication if possible

Exclusion criteria

  • contraindications for transcranial direct current stimulation
  • certain neurological conditions as assessed by study physician
  • participation in another study
  • pregnancy and lactation period

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

20 participants in 1 patient group

active treatment
Experimental group
Description:
2mA of tDCS for 20 min every weekday for six weeks
Treatment:
Device: home-based transcranial direct current stimulation (tDCS)

Trial contacts and locations

1

Loading...

Central trial contact

Martin Schecklmann; Tobias Hebel

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems